Skip navigation HCP China

OpGen

OpGen is commercializing a novel single molecule DNA analysis technology, "Optical Mapping", for rapid identification and analysis of microorganisms. The system can be used to obtain detailed genetic information with no requirement for prior sequence data, PCR, cloning, or probes. Applications of the new commercial systems include clinical microbial analysis, forensic microbiology and the development of novel molecular diagnostic products.

Recent News

Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks

BGI and OpGen Collaborate on Use of Optical Mapping for Whole Genome Assembly

OpGen Completes $17 Million Series B Financing

Industry Veteran Douglas White Appointed Chief Executive Officer of OpGen

OpGen Launches Argus Optical Mapping System for Automated, Microbial Whole Genome Analysis

OpGen’s Strategic Investment With In-Q-Tel Yields Commercial Availability of Optical Mapping Instrument

OpGen Announces Strategic Investment and Technology Advancement Agreement with In-Q-Tel